Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation

Biomolecules. 2023 May 10;13(5):812. doi: 10.3390/biom13050812.

Abstract

Background: The mycobacterial PE_PGRS protein family is present only in pathogenic strains of the genus mycobacterium, such as Mtb and members of the MTB complex, suggesting a likely important role of this family in pathogenesis. Their PGRS domains are highly polymorphic and have been suggested to cause antigenic variations and facilitate pathogen survival. The availability of AlphaFold2.0 offered us a unique opportunity to better understand structural and functional properties of these domains and a role of polymorphism in Mtb evolution and dissemination.

Methods: We made extensive use of AlphaFold2.0 computations and coupled them with sequence distribution phylogenetic and frequency analyses, and antigenic predictions.

Results: Modeling of several polymorphic forms of PE_PGRS33, the prototype of the PE_PGRS family and sequence analyses allowed us to predict the structural impact of mutations/deletions/insertions present in the most frequent variants. These analyses well correlate with the observed frequency and with the phenotypic features of the described variants.

Conclusions: Here, we provide a thorough description of structural impacts of the observed polymorphism of PE_PGRS33 protein and we correlate predicted structures to the known fitness of strains containing specific variants. Finally, we also identify protein variants associated with bacterial evolution, showing sophisticated modifications likely endowed with a gain-of-function role during bacterial evolution.

Keywords: PE_PGRS; polymorphism; protein structure; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins / metabolism
  • Mutation
  • Mycobacterium tuberculosis* / metabolism
  • Phylogeny
  • Polymorphism, Genetic

Substances

  • Bacterial Proteins

Grants and funding

Authors were funded through the project INF-ACT “One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases PE00000007”, PNRR Mission 4, funded by EU “NextGenerationEU”- D.D. MUR Prot.n. 0001554 of 11/10/2022. E.K. was funded by BactiVax—Anti-Bacterial Innovative Vaccines, Marie Skłodowska-Curie Actions, GA 860325.